{"id":"W3082840399","doi":"10.1158/1538-7445.am2020-ct109","title":"Abstract CT109: A phase I/Ib study evaluating GDC-0077 plus fulvestrant in patients with <i>PIK3CA</i>-mutant, hormone receptor-positive/HER2-negative breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Fulvestrant; Adverse effect; Breast cancer; Pharmacokinetics; Pharmacodynamics; Internal medicine; Cancer; Cmax; Dysgeusia; Oncology; Pharmacology; Estrogen receptor; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001088597,0.001786205,0.002023627,0.0006423882,0.0004790147,0.001128706,0.001279992,0.00123719,0.006876065],"category_scores_gemma":[0.0008643775,0.0005393581,0.001322704,0.0007601344,0.001128853,0.0009887528,0.0004698094,0.003995044,0.002064421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001434743,"about_ca_system_score_gemma":0.002500802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002596878,"about_ca_topic_score_gemma":0.006343524,"domain_scores_codex":[0.9996312,0.0001645531,0.00002448234,0.00006799672,0.0000409981,0.00007084255],"domain_scores_gemma":[0.9994183,0.0000697073,0.00007642056,0.00004590188,0.00003726181,0.0003524417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.699755,0.07781485,0.007635102,0.00146446,0.002015759,0.0006641198,0.0002785136,0.004002475,0.1026504,0.0003852592,0.008008259,0.09532573],"study_design_scores_gemma":[0.4959708,0.4818383,0.01107743,0.00006390816,0.0006085683,0.0004539804,0.00007798414,0.0009466019,0.005263049,0.0001260976,0.003530392,0.0000427892],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9833003,0.002294567,0.0006353657,0.0007238832,0.0001567349,0.004619931,0.003290397,0.0002273275,0.004751493],"genre_scores_gemma":[0.9804978,0.001992661,0.001901901,0.001279026,0.0001608974,0.002860388,0.006910799,0.00006232755,0.004334066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006876065,"threshold_uncertainty_score":0.02300268,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08345085841686188,"score_gpt":0.4375639325702059,"score_spread":0.354113074153344,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}